Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support

Nature Reviews Cardiology

Volumn 9, Issue 4, 2012, Pages 195-208

  Westaby, Stephen ^a   Anastasiadis, Kyriakos ^b   Wieselthaler, George M ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; AORTA BALLOON; ARTIFICIAL HEART; ASSISTED CIRCULATION; BLOOD PUMP; BRAIN INJURY; CARDIOGENIC SHOCK; DRESSLER SYNDROME; EXTRACORPOREAL OXYGENATION; HEART HEMODYNAMICS; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LIMB ISCHEMIA; MULTIPLE ORGAN FAILURE; OXYGENATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; REVIEW; RIGHT VENTRICULAR ASSIST DEVICE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ACUTE CORONARY SYNDROME; ANIMALS; ASSISTED CIRCULATION; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; INTRA-AORTIC BALLOON PUMPING; PROSTHESIS DESIGN; RESUSCITATION; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 84859111492     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.205     Document Type: Review

References (105)

1. Mullens, W. et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. Coll. Cardiol. 53, 589-596 (2009).
2. Rose, E. A. et al. Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med. 345, 1435-1443 (2001).
3. Thiele, H., Allam, B., Chatellier, G., Schuler, G. & Lafont, A. shock in acute myocardial infarction: the Cape Horn for trials? Eur. Heart J. 31, 1828-1835 (2010).
4. Arzamendi, D. et al. New insights into the management of cardiogenic shock complicating myocardial infarction: role of urgent heart transplantation. J. Heart Lung Transplant. 27, 984-989 (2008).
5. Krishnamani, R., DeNofrio, D. & Konstam, M. A. Emerging ventricular assist devices for long-term cardiac support. Nat. Rev. Cardiol. 7, 71-76 (2010).
6. Reynolds, H. R. & Hochman, J. S. Cardiogenic shock: current concepts and improving outcomes. Circulation 117, 686-697 (2008).
7. Just, P. M. et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol. Dial. Tranpslant. 23, 2365-2373 (2008). (Pubitemid 351957587)
8. Thiele, H. & Schuler, G. Cardiogenic shock: to pump or not to pump? Eur. Heart J. 30, 389-390 (2009).
9. Kolyva, C., Pantalos, G. M., Pepper, J. R. & Kuis, A. W. How much of the intra-aortic balloon pump volume is displaced toward the coronary circulation? J. Thorac. Cardiovasc. Surg. 140, 110-116 (2010).
10. Cohen, M. et al. Intra-aortic balloon counterpulsation in US and non-US centers: results of the Benchmark Registry. Eur. Heart J. 24, 1763-1770 (2003). (Pubitemid 37236866)
11. Van de Werf, F. et al. Management of acute myocardial infarction in patients presenting with ST segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur. Heart J. 24, 28-66 (2003).
12. Ryan, T. J. et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J. Am. Coll. Cardiol. 34, 890-911 (1999). (Pubitemid 29436200)
13. Nordhaug, D., Steensrud, T., Muller, S. Husnes, K. V. & Myrmel, T. Intra-aortic balloon pumping improves hemodynamics and right ventricular efficiency in acute ischemic right ventricular failure. Ann. Thorac. Surg. 78, 1426-1432 (2004). (Pubitemid 39303872)
14. Yoshitani, H. et al. Effects of intra-aortic balloon counterpulsation on coronary pressure in patients with stenotic coronary arteries. Am. Heart J. 154, 725-731 (2007). (Pubitemid 47429584)
15. Katz, E. S., Tunick, P. A. & Kronzon, I. Observations of coronary flow augmentation and balloon function during intra-aortic balloon counterpulsation using transesophageal echocardiography. Am. J. Cardiol. 69, 1635-1639 (1992).
16. Bonios, M. J. et al. Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion. Int. J. Cardiol. 138, 253-260 (2010).
17. Westaby, S., Balacumaraswami, L. & Sayeed, R. Maximising survival potential in very high risk cardiac surgery. Heart Fail. Clin. 3, 159-180 (2007). (Pubitemid 47069964)
18. Christenson, J. T. et al. Trends in intra-aortic balloon counterpulsation complications and outcomes in cardiac surgery. Ann. Thorac. Surg. 74, 1086-1090 (2002). (Pubitemid 35176722)
19. Hochman, J. S. et al. Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome: A report from the SHOCK trial registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J. Am. Coll. Cardiol. 36, 1063-1070 (2000).
20. Barron, H. V. et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am. Heart J. 141, 933-939 (2001).
21. Sjauw, K. D. et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST elevation myocardial infarction: should we change the guidelines. Eur. Heart J. 30, 459-468 (2009).
22. Ohman, E. M. & Hochman, J. S. Aortic counterpulsation in acute myocardial infarction: physiologically important but does the patient benefit? Am. Heart J. 141, 889-892 (2001). (Pubitemid 32476998)
23. Cheng, J. M. et al. Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta analysis of controlled trials. Eur. Heart J. 30, 2102-2108 (2009).
24. Stone, G. W. et al. Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. Am. J. Cardiol. 85, 1292-1296 (2000). (Pubitemid 30314659)
25. Morrow, D. A. et al. Concurrent evaluations of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD409 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur. Heart J. 29, 1096-1102 (2008). (Pubitemid 351844877)
26. US National Institutes of Health. Intra-aortic Balloon Pump in Cardiogenic Shock II (IABP - SHOCK II). ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00491036 (2011).
27. Jeger, R. V. et al. Emergency early revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur. Heart J. 27, 664-670 (2006).
28. Garcia-Alvarez, A. et al. Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention. Am. J. Cardiol. 103, 1073-1077 (2009).
29. Wong, S. C. et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J. Am. Coll. Cardiol. 36 (Suppl. A), 1077-1083 (2000).
30. Burkhoff, D., Cohen, H., Brunckhorst, C. & O'Neill, W. W for the TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the Tandem Heart percutaneous ventricular assist device versus conventional therapy with intra-aortic balloon pumping for treatment of cardiogenic shock. Am. Heart J. 152, 469.e1-469.e8 (2006).
31. Dixon, S. R. et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT 1 trial): initial US experience. JACC Cardiovasc. Interv. 2, 91-96 (2009).
32. Henriques, J. P. & de Mol B. A. New percutaneous mechanical left ventricular support for acute MI: the AMC MACH program. Nat. Clin. Pract. Cardiovasc. Med. 5, 62-63 (2008). (Pubitemid 351168055)
33. Theile, H. et al. Randomized comparison of intra-aortic balloon pump support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur. Heart J. 26, 1276-1283 (2005).
34. Meyns, B., Stolinski, J., Leunens, V., Verbeten, E. & Flameng, W. Left ventricular support by catheter mounted axial flow pump reduces infarct size. J. Am. Coll. Cardiol. 41, 1087-1095 (2003). (Pubitemid 36384893)
35. Sjauw, K. D. et al. Left ventricular unloading in acute ST segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J. Am. Coll. Cardiol. 51, 1044-1046 (2008). (Pubitemid 351318126)
36. Sjauw, K. D. et al. Supported high-risk percutaneous coronary interventions with the Impella 2.5 device: the Europella registry. J. Am. Coll. Cardiol. 54, 2430-2434 (2009).
37. Lamarche, Y. et al. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J. Thorac. Cardiovasc. Surg. 142, 60-65 (2011).
38. Seyfarth, M. et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J. Am. Coll. Cardiol. 52, 1584-1588 (2008).
39. Thiele, H. et al. Reversal of cardiogenic shock by percutaneous left atrial to femoral arterial bypass assistance. Circulation 104, 2917-2922 (2001). (Pubitemid 33139103)
40. Kar, B., Gregoric, I. D., Basra, S. S., Idelchick, G. M. & Loyalka, P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J. Am. Coll. Cardiol. 57, 688-696 (2011).
41. Hochman, J. S. et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N. Engl. J. Med. 341, 625-634 (1999).
42. Kohsaka, S. et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch. Intern. Med. 165, 1643-1650 (2005). (Pubitemid 41124160)
43. Vranckx, P. et al. The Tandem Heart, percutaneous trans-septal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six year Rotterdam experience. EuroIntervention 4, 331-337 (2008).
44. Mahmoudi, M., Syed, A. I. & Waksman, R. The role of percutaneous circulatory assist devices in acute myocardial infarction and high-risk percutaneous intervention in the 21st century. Cardiovasc. Revasc. Med. 12, 237-242 (2011).
45. Al-Husami, W. et al. Single-center experience with the Tandem Heart percutaneous ventricular assist device to support patients undergoing high risk percutaneous coronary intervention. J. Invasive Cardiol. 20, 319-322 (2008). (Pubitemid 351940888)
46. Smedira, N. G. et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J. Thorac. Cardiovasc. Sug. 122, 92-102 (2001).
47. Massetti, M. et al. Back from irreversibility: extracorporeal life support for prolonged cardiac arrest. Ann. Thorac. Surg. 79, 178-183 (2005). (Pubitemid 40037462)
48. Feindt, P. et al. Use of extracorporeal circulation (ECC) outside the cardiac operating room: indications, requirements and recommendations for routine practice. Thorac. Cardiovasc. Surg. 59, 66-68 (2011).
49. Avalli, L. et al. Percutaneous left heart decompression during extracorporeal membrane oxygenation: an alternative to surgical and transeptal venting in adult patients. ASAIO J. 57, 38-40 (2011).
50. Schmid, C., Philipp, A., Mueller, T. & Hilker, M. Extracorporeal life support-systems, indications, and limitations. Thorac. Cardiovasc. Surg. 57, 449-454 (2009).
51. Sheu, J. T. et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit. Care Med. 38, 1810-1817 (2010).
52. Fujimoto, K. et al. Percutaneous extracorporeal life support for treatment of fatal mechanical complications associated with acute myocardial infarction. Artif. Organs 25, 1000-1003 (2001). (Pubitemid 34107309)
53. Hoefer, D. et al. Outcome evaluation of bridge to bridge concept in patients with cardiogenic shock. Ann. Thorac. Surg. 82, 28-33 (2006).
54. Pagani, F. D., Aaronson, K. D., Swaniker, F. & Bartlett, R. H. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann. Thorac. Surg. 71, 77-81 (2001).
55. Yamauchi, T., Masai, T., Takeda, K., Kainuma, A. & Sawa, Y. Percutaneous cardiopulmonary support after acute myocardial infarction at the left main trunk. Ann. Thorac. Cardiovasc. Surg. 15, 93-97 (2009).
56. Russo, C. F. et al. Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock. J. Thorac. Cardiovasc. Surg. 140, 1416-1421 (2010).
57. Formica, F., Avalli, L., Redaelli, G. & Paolini, G. Interhospital stabilisation of adult patients with refractory cardiogenic shock by veno-arterial extracorporeal membrane oxygenation. Int. J. Cardiol. 147, 164-165 (2011).
58. Artl, M. et al. First experience with a new miniaturised life support system for mobile percuatneous cardiopulmonary bypass. Resuscitation 77, 345-350 (2008).
59. Slaughter, M. S. et al. Results of a multicenter trial with the Thoratec implantable ventricular assist device. J. Thorac. Cardiovasc. Surg. 133, 1573-1580 (2007).
60. Gray, L. A. Jr. & Champsaur, G. G. The BVS 5000 biventricular assist device. The worldwide registry experience. ASAIO J. 40, M460-M464 (1994). (Pubitemid 24364246)
61. Leshnower, B. G. et al. Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann. Thorac. Surg. 81, 1365-1370 (2006).
62. Holman, W. L. et al. INTERMACS: interval analysis of registry data. J. Am. Coll. Surg. 208, 755-761 (2009).
63. John, R. et al. Experience with the Levitronix CentriMag circulatory support system as bridge to decision in patients with refractory cardiogenic shock and multisystem organ failure. J. Thorac. Cardiovasc. Surg. 134, 351-358 (2007). (Pubitemid 47088583)
64. John, R. et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J. Thorac. Cardiovasc. Surg. 141, 932-939 (2010).
65. Haj-Yahia, S. et al. Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump. J. Thorac. Cardiovasc. Surg. 138, 227-230 (2009).
66. Anderson, M. et al. Use of the AB 5000 ventricular assist device in cardiogenic shock after acute myocardial infarction. Ann. Thorac. Surg. 90, 706-712 (2010).
67. Dang, N. C. et al. Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: a two-center study. J. Thorac. Cardiovasc. Surg. 130, 693-698 (2005). (Pubitemid 41265706)
68. Tayara, W. et al. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J. Heart Lung Transplant. 25, 504-509 (2006). (Pubitemid 44308155)
69. Park, S. J., Nguyen, D. Q., Bank, A. J. Ormaza, S. & Bolman, R. M. 3rd Left ventricular assist device bridge therapy for acute myocardial infarction. Ann. Thorac. Surg. 69, 1146-1151 (2000). (Pubitemid 30259376)
70. Lahm, T. et al. Medical and surgical treatment of acute right ventricular failure. J. Am. Coll. Cardiol. 56, 1435-1446 (2010).
71. Ochiai, Y. et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106 (Suppl. I), I198-I202 (2002).
72. Morgan, J. A. et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality? Ann. Thorac. Surg. 77, 859-863 (2004). (Pubitemid 38271049)
73. Fitzpatrick, J. R. 3rd. et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J. Thorac. Cardiovasc. Surg. 137, 971-977 (2009).
74. Saito, S., Nishinaka, T. & Westaby, S. Hemodynamics of chronic non pulsatile flow: implications for LVAD development. Surg. Clin. North Am. 84, 61-74 (2004). (Pubitemid 38229968)
75. Slaughter, M. S. et al. Advanced heart failure treated with a continuous-flow left ventricular assist device. N. Engl. J. Med. 361, 2241-2251 (2009).
76. Westaby, S. et al. Destination therapy with a rotary blood pump and novel power delivery. Eur. J. Cardiothorac. Surg. 37, 350-356 (2010).
77. Hetzer, R. et al. First experiences with a novel magnetically suspended axial flow left ventricular assist device. Eur. J. Cardiothorac. Surg. 25, 964-970 (2004). (Pubitemid 38622336)
78. Strueber, M. et al. Multicenter evaluation of an intrapericardial left ventricular assist system. J. Am. Coll. Cardiol. 57, 1375-1382 (2011).
79. Morshuis, M. et al. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur. J. Cardiothorac. Surg. 35, 1020-1027 (2009).
80. MacGowan, G. A., Parry, G., Schueler, S. & Hasan, A. The decline in heart transplantation in the UK. BMJ 342, d2483 (2011).
81. Westaby, S. Editorial comment. Tricuspid regurgitation in left ventricular assist device patients. Eur. J. Cardiothorac. Surg. http://dx.doi.org/10.1016/j.ejcts.2011.06.019.
82. Pal, J. D. et al. Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. Circulation 120, S215-S219 (2009).
83. Slepian, M. J. & Copeland, J. G. The total artificial heart in refractory cardiogenic shock: saving the patient versus saving the heart. Nat. Clin. Pract. Cardiovasc. Med. 5, 64-65 (2008). (Pubitemid 351168056)
84. Copeland, J. G. et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N. Engl. J. Med. 351, 859-867 (2004). (Pubitemid 39099324)
85. Roussel, J. C. et al. CardioWest (Jarvik) total artificial heart: a single center experience with 42 patients. Ann. Thorac. Surg. 87, 124-130 (2009).
86. Morales, D. L. et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann. Thorac. Surg. 69, 102-106 (2000). (Pubitemid 30078830)
87. Thiemermann, C., Szabó, C., Mitchell, J. A. & Vane, J. R. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl Acad. Sci. USA 90, 267-271 (1993). (Pubitemid 23010291)
88. Landry, D. W. & Oliver, J. A. The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J. Clin. Invest. 89, 2071-2074 (1992).
89. Szabó C. & Salzman, A. L. Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. Shock 5, 391-394 (1996). (Pubitemid 126727702)
90. Cotter, G. et al. LINCS: L NAME (a No Synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur. Heart J. 24, 1287-1295 (2003). (Pubitemid 36917699)
91. Argenziano, M. et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 96 (Suppl. 9), II286-II290 (1997). (Pubitemid 27500045)
92. Braunwald, E. & Wagner, H. N. Jr. The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J. Clin. Invest. 35, 1412-1418 (1956).
93. Howel, J. & Wheatley, M. Molecular pharmacology of V1a vasopressin receptors. Gen. Pharmacol. 26, 1143-1152 (1995).
94. Kusano, E. et al. Arginine vasopressin inhibits interleukin 1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells. J. Hypertens. 15, 627-632 (1997). (Pubitemid 27246539)
95. Edwards, R. M., Rinza, W. & Kinter, L. B. Renal microvascular effects of vasopressin and vasopressin antagonist. Am. J. Physiol. 256 (2 Pt 2), F274-F278 (1989).
96. El-Banayosy, A. et al. A multidisciplinary network to save the lives of severe persistent cardiogenic shock patients. Ann. Thorac. Surg. 80, 543-547 (2005). (Pubitemid 41019476)
97. Foley, D. S. et al. A review of 100 patients transported on extracorporeal life support. ASAIO J. 48, 612-619 (2002). (Pubitemid 35285513)
98. Aggarwal, S. & Pagani, F. D. Bridge to transplantation: current outcomes. J. Card. Surg. 25, 455-461 (2010).
99. Joyce, D. L., Conte, J. V., Russell, S. D., Joyce, L. D. & Chang, D. C. Disparities in access to left ventricular assist device therapy. J. Surg. Res. 152, 111-117 (2009).
100. General Medical Council. Treatment and care towards the end of life: good practice in decision making [online], www.gmc-uk.org/End-of-life.pdf-32486688. pdf (2010).
101. Messori, A. et al. Left ventricular assist device as destination therapy: application of the payment by results approach for the device reimbursement. J. Thorac. Cardiovasc. Surg. 138, 480-485 (2009).
102. Pearson, S. D., Rawlins, M. D. Quality, innovation and value for money - NICE and the British National Heath Service. JAMA 294, 2618-2622 (2005). (Pubitemid 41697251)
103. MacGowan, G. A., Parry, G., Schueler, S. & Hasan, A. The decline in heart transplantation in the UK. BMJ 342, d2483 (2011).
104. Westaby, S. Lifetime circulatory support must not be limited to transplant centers. Heart Fail. Clin. 3, 369-375 (2007). (Pubitemid 47302404)
105. Kherani, A. R. et al. Implantation of a left ventricular assist device and the hub and spoke system in treating acute cardiogenic shock: who survives? J. Thorac. Cardiovasc. Surg. 126, 1634-1635 (2003). (Pubitemid 37449198)